China should not prioritise low prices in drug procurement plan, European lobby group says
A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...
MedPage Today on MSN1d
Approved Sickle Cell Drug Fails to Beat Placebo in Trial
Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
GlobalData on MSN5d
AstraZeneca and Ionis win EU approval for ATTR polyneuropathy
AstraZeneca and Ionis Pharmaceuticals’ polyneuropathy drug has won approval in the European Union (EU), where it will be ...
The Pharma Letter5d
EU nod next for ATTRv-PN drug
AstraZeneca and Ionis’ Wainzua (eplontersen) has been approved in the European Union (EU) for the treatment of hereditary ...
Can BIIB's New Drugs Revive Growth as Multiple Sclerosis Sales Fall?
Biogen believes that some of its new drugs, Leqembi, Skyclarys and Zurzuvae, have the potential to revive long-term growth. Can Biogen achieve this goal?
The Pharma Letter2d
Rxulti now approved for adolescents in Europe
The European Commission (EC) has approved Danish CNS specialist Lundbeck (LUND: CO) and Otsuka Europe’s Rxulti ...
Pharmaceutical Technology on MSN1d
Unsafe and unregulated cell therapies being sold in Europe
The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...
EL PAÍS English3d
The most expensive drug ever approved: A gene therapy that cures butterfly skin and could cost $20 million per patient
Mía had dystrophic epidermolysis bullosa, better known as butterfly skin due to the extreme fragility of this tissue in ...
Business Wire4d
Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today an ...
Medscape2d
Do We Know Enough About Assisted Dying Drugs?
Amid the ethical and legal arguments, a fundamental question remains: How much do we truly understand about the drugs used in ...
Devdiscourse4d
EU's Critical Medicines Act: A Step Towards Pharmaceutical Independence
The European Commission's Critical Medicines Act aims to reduce the EU's dependence on countries like China and India for ...
pharmaphorum2d
EMA’s strategy for speeding up drug approvals in the EU
The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike. Following a turbulent period marked by Brexit and the ...